Loading insider details...
Beta
Latest Form 4 (Jan 7, 2026): Grant/Award of 2,500 DRMA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 7, 2026 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 2,500 | n/a |
| Jan 14, 2025 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 5,000 | n/a |
| Jan 5, 2024 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 10,000 | n/a |
| Oct 7, 2022 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 10,120 | n/a |
| Jul 8, 2022 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 8,874 | n/a |
| Apr 8, 2022 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 5,190 | n/a |
| Jan 6, 2022 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 5,000 | n/a |
| Aug 17, 2021 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 10,000 | n/a |